See on välja mõelnud ravimeid nende liikide jaoks, kes on meile õed-vennad; eriti loodame Yaohai abil oma lemmikloomade ja kasside eest paremini hoolitseda. Teist nimetatakse rekombinantseks kasside seerumi albumiiniks või lühendatult FSA. Kassispetsiifilised antikehad – teatud tüüpi valk, mis esineb kasside veres, seega FSA Kuid see FSA ei saadud autentsest kittyst, mis teeb selle "rekombinantseks" FSA Kuidas saame tuua katatakti sügavamasse näidesse Kass poisid on sõltuvuses. — Täiesti uudse ja asendamatu ravimina ajaproov / suurepärased tulemused kõigi teiste praegu saadaolevate vadakutoidutoodete puhul.
FSA vabatahtlikud teevad haigete kasside eest hoolitsemise nimel kõvasti tööd. 5) Valkude kaitse Kui kassid haigestuvad, võivad nad kaotada oma kehas üsna palju olulisi valke. Valgu kadu võis muuta nad nõrgaks ja väsinuks, nii et nende keha võis haigusega võidelda. Laske FSA-l asendada see, mida nad on proteiinis kaotanud. Kuid see võib panna teise halva olukorra kiiremini mööduma ja tuua nad väljakule tagasi enne, kui arugi saad. Ja erinevalt IFATist, Yaohai Rekombinantne inimese seerumi albumiin (HSA) saab kasutada kasside puhul, kes pole kunagi haiged olnud. Parandades nende immuunsüsteemi, hoiate ära nende haigestumise.
Äärmiselt oluline, kuna FSA asendab kasside kadunud valku. Nad vajavad seda taastumiseks. Näiteks võib täpselt see valk panna kassile tunde, et ta on tõusuteel ja paraneb haigena kiiremini. See on ka ennetav vahend, et hoida neid tervena FSA-na. See muudetakse süstiks, millele kassidele süstitakse. Yaohai Suure saagisega plasmiidi fermentatsioon võib takistada kassi haigestumist, see on suurepärane. FSA on olemas kõikidel kassidel, mis muudab nad nende eluea jooksul tugevaks ja terveks.
Kuigi need tükitöö kirjutajad tegid oma tööd, on mõned teadlased püüdnud välja selgitada ja mõista FSA eeliseid kassidele. "Kuigi nad tunnistavad, et FSA on haigete kasside jaoks hea asi, peavad nad seda ka millekski, mis hoiab ära tervete kasside haigestumise. Seetõttu on FSA kindlasti üks peamisi ravimeid, mida me oma kasside tervena hoidmise vastu võitlemisel kasutame. Selle teabega Yaohais uue ajastu pioneeridena Albumiini siduva kasvuhormooni tootmine, saavad nüüd rohkem kassid väärtuslikust ravimist, mida saab selle abil valmistada. See on tohutu samm edasi loomameditsiinis ja võimalus muuta lugematute kasside elusid.
Tulevikus on FSA kasside jaoks olulisem. Järeldus: FSA lahkamiseks mõeldud tulevane uurimine loob uued mehhanismid FSA kasulikkuse ümber ja toob lõpuks kaasa uued võimalused FSA jaoks biomeditsiinis. Yaohai eesmärk on muuta FSA toodetud universaalseks, mis võimaldab tulevikus rohkem kassipopulatsioone aidata. Kuna kassid on kohustuslikud lihasööjad ja täidavad lihatarbimise kaudu kõiki hüdrooni nõudeid, jääb FSA järele tõenäoliselt veterinaarmeditsiinis nõutuks veel paar aastat.
Yaohai Bio-Pharma, a leader in Recombinant Feline Serum Albumin (FSA) of microbial biologics, is located in Jiangsu. We are focusing on microbially produced therapeutics and vaccines that are suited for human, veterinary, and pet health management. We have modern RD as well as manufacturing technology platforms that cover the entire process, from engineering microbial strains, cell banking, process and method development, through to commercial and clinical manufacturing, making sure that we can ensure the successful supply of the most cutting-edge solutions. We have acquired a large amount of experience in the microbial bio processing field. More than 200 projects have been completed successfully and we support our clients in overcome regulations such as those of the US FDA and EU EMA. We also aid them with Australia TGA and China NMPA. We are able to respond rapidly to market requirements and offer customized CDMO services thanks to our experience and expertise.
Yaohai Bio-Pharma, a top 10 manufacturer of biological products, specializes in microbial fermentation. We have created a Recombinant Feline Serum Albumin (FSA) manufacturing facility with robust RD capabilities and cutting-edge manufacturing facilities. Five drug substance production lines conforming to GMP standards to purify and ferment microbial cells, as well as two fill and finish lines for vials and cartridges, as well as needles that are pre-filled, are available. The available fermentation scales include 100L, 500L, 1000L and 2000L. Specifications for filling vials range from 1ml - 25ml. the pre-filled cartridge or syringe filling specifications range from between 1-3ml. The production workshop is cGMP-compliant and provides a stable supply of commercial products and clinical samples. Our facility produces large molecules that are shipped worldwide.
Yaohai BioPharma, a top 10 Microbial CDMO, integrates quality and regulatory matters. We have a quality system that is fully compliant with the current GMP standards, as well as international regulations. Our team of regulatory experts has a deep understanding of world-wide regulatory frameworks. This lets us accelerate biological launches. We are able to guarantee traceable production procedures and high-quality products that conform with regulations from the US FDA, Recombinant Feline Serum Albumin (FSA), Australia TGA, and China NMPA. Yaohai BioPharma has successfully passed an on-site audit conducted of the European Union's Qualified Person (QP) for our GMP quality system and production site. We also have been through the initial certification audits of the ISO9001 Quality Management System and ISO14001 Environmental Management System.
Yaohai Bio-Pharma is Recombinant Feline Serum Albumin (FSA) in microbial-derived biologics. We offer custom RD as well as manufacturing solutions, while minimising the risk. We've been involved in numerous modalities like recombinant subunit vaccines, peptides hormones, cytokines growth factors, single-domain antibodies, enzymes, plasmid DNA, the mRNA, and other. We are experts in several Microbial hosts, such as yeast extracellular and intracellular (yield up to 15 grams per liter) bacteria periplasmic secretion as well as soluble intracellular inclusion bodies (yield up to 10 grams/L). Additionally, we have developed the BSL-2 microbial fermentation platform for the development of bacterial vaccines. We have a track record of improving production processes, thereby increasing yields, and reducing costs. With a highly efficient technology team, we guarantee prompt and reliable project delivery and bring your products to market quicker.